Cefixime Patent Expiration

Cefixime is Used for treating bacterial infections. It was first introduced by Lederle Laboratories Div American Cyanamid Co in its drug Suprax on Apr 28, 1989. 7 different companies have introduced drugs containing Cefixime.


Cefixime Patents

Given below is the list of patents protecting Cefixime, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Suprax US9233112 Pharmaceutical compositions of cefixime Dec 14, 2028 Lupin Ltd


Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳

Cefixime Generics

Several generic applications have been filed for Cefixime. The first generic version for Cefixime was by Lupin Pharmaceuticals Inc and was approved on Feb 12, 2004. And the latest generic version is by Alkem Laboratories Ltd and was approved on Feb 19, 2021.

Given below is the list of companies who have filed for Cefixime generic.


1. LUPIN LTD

Lupin Ltd has filed for 3 different strengths of generic version for Cefixime. All of these versions come by the name SUPRAX. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet, chewable Prescription ORAL N/A Oct 25, 2010
150MG tablet, chewable Prescription ORAL N/A Oct 25, 2010
200MG

(reference standard)

tablet, chewable Prescription ORAL N/A Oct 25, 2010


2. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Cefixime. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/5ML for suspension Prescription ORAL AB Apr 14, 2015
200MG/5ML for suspension Prescription ORAL AB Apr 14, 2015


3. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 3 different strengths of generic version for Cefixime. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
400MG capsule Prescription ORAL AB Oct 9, 2018
100MG/5ML for suspension Prescription ORAL AB Feb 19, 2021
200MG/5ML for suspension Prescription ORAL AB Feb 19, 2021


4. LUPIN PHARMS

Lupin Pharmaceuticals Inc has filed for 3 different strengths of generic version for Cefixime. All of these versions come by the name SUPRAX. Given below are the details of the strengths of this generic introduced by Lupin Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
400MG tablet Discontinued ORAL N/A Feb 12, 2004
100MG/5ML for suspension Discontinued ORAL N/A Feb 23, 2004
200MG/5ML

(reference standard)

for suspension Prescription ORAL AB Apr 10, 2007


5. BELCHER

Belcher Pharmaceuticals Llc has filed for 3 different strengths of generic version for Cefixime. Given below are the details of the strengths of this generic introduced by Belcher.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG/5ML for suspension Prescription ORAL AB Feb 6, 2017
200MG/5ML for suspension Prescription ORAL AB Feb 6, 2017
500MG/5ML for suspension Prescription ORAL AB Feb 6, 2017


6. SANDOZ

Sandoz Inc has filed for 2 different strengths of generic version for Cefixime. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/5ML for suspension Discontinued ORAL N/A Nov 17, 2017
100MG/5ML for suspension Discontinued ORAL N/A Nov 17, 2017